Japanese stocks remain steady, with TPX ending -0.4% lower. However, TPX saw gain of 5% for Nov. Taisho Pharma surges 57% on MBO plans, while Shiseido sees a 9% decline as sell-side cuts numbers.
SUMMARY
(Sign Up to Access)
Begin exploring Smartkarma's AI-augmented investing intelligence platform with a complimentary Preview Pass to:
Unlock research summaries
Follow top, independent analysts
Receive personalised alerts
Access Analytics, Events and more
Join 55,000+ investors, including top global asset managers overseeing $13+ trillion.